These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. India's patent ecosystem - encouraging strong patents or discouraging innovation? Harrison C Nat Rev Drug Discov; 2013 Oct; 12(10):732-3. PubMed ID: 24080690 [No Abstract] [Full Text] [Related]
7. Balancing access and innovation: India's Supreme Court rules on imatinib. Rajkumar R; Kesselheim AS JAMA; 2013 Jul; 310(3):263-4. PubMed ID: 23824051 [No Abstract] [Full Text] [Related]
8. Access to medicine and the dangers of patent linkage: lessons from Bayer Corp v. Union of India. Tsui M J Law Med; 2011 Mar; 18(3):577-88. PubMed ID: 21528741 [TBL] [Abstract][Full Text] [Related]
9. India's patent laws and the multinational pharmaceutical industry. Srinivasan S; Bharadwaj K Natl Med J India; 2013; 26(3):128-32. PubMed ID: 24476157 [No Abstract] [Full Text] [Related]
10. Impact of India's new patents law 2005: a physician's perspective. Lele RD J Assoc Physicians India; 2005 Aug; 53():671-5. PubMed ID: 16398073 [No Abstract] [Full Text] [Related]
17. India's rejection of Novartis's patent is but a small step in the right direction. Bhaumik S BMJ; 2013 Apr; 346():f2412. PubMed ID: 23596223 [No Abstract] [Full Text] [Related]
18. The biotechnology industry organization's view on Hatch-Waxman reform. Schmickel D Food Drug Law J; 1999; 54(2):241-2. PubMed ID: 11758580 [No Abstract] [Full Text] [Related]
19. Changes to India's patent law: integrated approach is needed. Barker R BMJ; 2005 Apr; 330(7498):1025. PubMed ID: 15860837 [No Abstract] [Full Text] [Related]
20. New negotiations with Europe may threaten India's ability to export generic drugs to countries that need them the most. Verma P; Berg T; Liao JF Natl Med J India; 2011; 24(3):191. PubMed ID: 21786860 [No Abstract] [Full Text] [Related] [Next] [New Search]